ClinicalTrials.Veeva

Menu

Previvors Recharge: A Resilience Program for Cancer Previvors (PreCharge)

Pro-Change Behavior Systems logo

Pro-Change Behavior Systems

Status

Completed

Conditions

Mental Health Issue
Hereditary Cancer

Treatments

Behavioral: PreCharge

Study type

Interventional

Funder types

Other

Identifiers

NCT06378749
1R43CA275673

Details and patient eligibility

About

It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals with an HCS who have never been diagnosed with cancer (Previvors) have up to an 80% lifetime risk of developing cancer and are at an increased risk of developing multiple primary cancers during their lifetime, often with onset at an early age. Previvors face multiple forms of adversity, including a multitude of annual cancer screenings and the uncertainty of not only their own health but the health of affected family members. This study will examine the acceptability and preliminary effects of PreCharge, a resilience-boosting solution specifically designed for Previvors and delivered primarily via bi-directional text messaging. PreCharge uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose while also proactively addressing scanxiety. Up to 150 Hereditary Cancer Previvors will be recruited for a 30-day pilot test. Participants will complete a baseline assessment, and then be provided with 30 days of access to the PreCharge program. At the end of the 30 days, they will be prompted to complete a follow-up assessment. Outcomes to be examined will include pre-post changes on the Connor Davidson Resilience Scale.

Enrollment

138 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Identified as having Hereditary Cancer Syndrome
  2. Never having been diagnosed with cancer
  3. Over 18 years of age
  4. Living in the United States
  5. English speaking
  6. Having a score of 26 or below on the Connor Davidson Resilience Scale (10 Item)
  7. Access to a mobile phone
  8. Agree to receive text messages.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

138 participants in 1 patient group

PreCharge Intervention Pilot
Experimental group
Description:
After completing the baseline assessment, all pilot participants will have access to the PreCharge pilot program for 30 days. At the end of the 30 day pilot, they will be directed to the follow-up assessment.
Treatment:
Behavioral: PreCharge

Trial documents
3

Trial contacts and locations

1

Loading...

Central trial contact

Madison Gilmore; Kerry E Evers, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems